cbdMD (NYSEAMERICAN:YCBD) Shares Down 0.1% – Time to Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD) dropped 0.1% during trading on Friday . The company traded as low as $0.56 and last traded at $0.5650. Approximately 105,812 shares were traded during trading, a decline of 57% from the average session volume of 245,720 shares. The stock had previously closed at $0.5657.

cbdMD Stock Performance

The firm’s fifty day moving average price is $0.65 and its two-hundred day moving average price is $0.75.

cbdMD (NYSEAMERICAN:YCBD) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). The firm had revenue of $5.64 million for the quarter, compared to analysts’ expectations of $5.29 million. cbdMD had a negative return on equity of 33.60% and a negative net margin of 13.29%.

Hedge Funds Weigh In On cbdMD

An institutional investor recently bought a new stake in cbdMD stock. Jane Street Group LLC bought a new stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned approximately 0.49% of cbdMD as of its most recent SEC filing. Institutional investors own 7.18% of the company’s stock.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.